William R. Friedenberg

A phase 3 study of three induction regimens and of priming with GM-CSF in older adults with acute myeloid leukemia: a trial by the Eastern Cooperative Oncology Group

Jacob M. Rowe, Donna Neuberg, William R. Friedenberg et al. · Blood · 2003 · 275 citations · Full text

Recombinant tissue-type plasminogen activator versus a novel dosing regimen of urokinase in acute pulmonary embolism: a randomized controlled multicenter trial

Samuel Z. Goldhaber, Craig M. Kessler, John A. Heit et al. · Journal of the American College of Cardiology · 1992 · 218 citations

Pulmonary Embolism, Translational Medicine, Thrombosis +6

Rituximab Therapy for Patients With Newly Diagnosed, Advanced-Stage, Follicular Grade I Non-Hodgkin's Lymphoma: A Phase II Trial in the North Central Cancer Treatment Group

Thomas E. Witzig, Allen M. Vukov, Thomas M. Habermann et al. · Journal of Clinical Oncology · 2005 · 202 citations · Full text

Phase III study of PSC‐833 (valspodar) in combination with vincristine, doxorubicin, and dexamethasone (valspodar/VAD) versus VAD alone in patients with recurring or refractory multiple myeloma (E1A95)

William R. Friedenberg, Montserrat Rué, Emily Blood et al. · Cancer · 2006 · 162 citations

Platelet Dysfunction Associated with Cardiopulmonary Bypass

William R. Friedenberg, William O. Myers, E. D. Plotka et al. · The Annals of Thoracic Surgery · 1978 · 98 citations

Thrombosis, Cardiovascular Disease, Blood Platelet +5